The FDA granted orphan drug designation to zavabresib, an investigational therapy for the treatment of myelofibrosis, a rare ...
Spleen stiffness measurement (SSM) demonstrated strong predictive accuracy for liver decompensation in patients with compensated advanced chronic liver disease (cACLD), with an optimal cutoff of 50 ...
Individuals with incidentally detected splenomegaly may be at increased risk for blood and liver cancers, as well as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results